Seeking Alpha
 

Cellceutix Corp. (CTIX)

- OTCPK - Current
  • ellaruth | Send Message 25 Jul

    $CTIX Cellceutix licensing strategy for Brilacidin= HAKUN MATATA!
    Reply
      • ellaruth | Send Message 25 Jul

        The Brilacidin Licensing Strategy: HAKUNA MATATA! $CTIX http://seekingalpha.com/p/2if3r
        Reply
          • ellaruth | Send Message 20 Jul

            Yahoo Boards IS Right $CTIX has reached its CRITICAL MASS. This will last 9-16 mos. The countdown begins.http://bit.ly/1DyBqMp
            Reply
              • ellaruth | Send Message 20 Jul

                Wisdom Cries From Yahoo's Board CELLCEUTIX HAS REACHED CRITICAL MASS $CTIX http://seekingalpha.com/p/2i1rh
                Reply
                  • ellaruth | Send Message 19 Jul

                    $CTIX Speculative price targets for 2016. Move of 500% expected by some shareholders.http://seekingalpha.com/p/2hzal
                    Reply
                      • ellaruth | Send Message 19 Jul

                        Speculative Price Targets For CTIX Shares From IHUB $CTIX http://seekingalpha.com/p/2hzal
                        Reply
                          • ellaruth | Send Message 15 Jul
                            Reply
                              • ellaruth | Send Message 15 Jul
                                Reply
                                  • ellaruth | Send Message 15 Jul

                                    Attention PolyMedix Shareholders: Brilacidin & Definsin's Are Free! $CTIX, $PYMXQ http://seekingalpha.com/p/2hr1x
                                    Reply
                                      • ellaruth | Send Message 15 Jul

                                        Why Would Johnson & Johnson Be Interested In Cellceutix? $CTIX, $JNJ http://seekingalpha.com/p/2hp79
                                        Reply
                                          Visit Seeking Alpha's
                                          CTIX vs. ETF Alternatives
                                          Company Description
                                          An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States